Refine
Has Fulltext
- yes (3)
Is part of the Bibliography
- yes (3)
Document Type
- Journal article (3)
Language
- English (3)
Keywords
- SARS-CoV-2 (3)
- Calu-3 (1)
- PCLS (1)
- Tamoxifen (1)
- Vero E6 (1)
- acetylsalicylic acid (1)
- antiviral activity (1)
- antivirals (1)
- aspirin (1)
- azapeptide nitriles (1)
- cell line specificity pyridyl indole carboxylates (1)
- cell line-specificity (1)
- peptidomimetics (1)
- phospholipidosis (1)
- precision-cut lung slices (1)
- protease inhibitors (1)
- salicylic acid (1)
Acetylsalicylic acid and salicylic acid inhibit SARS-CoV-2 replication in precision-cut lung slices
(2022)
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.